herb · for bloating
Milk Thistle
Meant to get bile flowing, which would help you digest fat and feel less full.
Say that in clinical terms
Stimulates bile production and flow, improving fat digestion and reducing postprandial bloating and fullness.
How strong is the research?
1 paper read.
Who was studied: Studied in people with fatty liver disease alongside indigestion — a specific clinical group.
No standalone silymarin trial was found that tests bloating as a primary or secondary outcome. The only trial touching silymarin and bloating is PMC9027095 (DOI 10.3390/jcm11082248, confirmed resolvable), which gave a fixed combination of inulin + choline + silymarin (Stoptoxin) to IBS-constipation patients. It found 34.8% improvement in abdominal bloating severity (p=0.040). However, because inulin (a well-established prebiotic with documented effects on gut gas and bloating) and choline are co-administered, the bloating improvement cannot be attributed to silymarin. No trial gives silymarin alone for bloating. The broader silymarin trial literature (NASH, hepatitis C, ulcerative colitis, a
How much to take
daily
200–400 mg
Most effective for functional dyspepsia. Take 30 minutes before meals.
Before you take it
- No established NIH/IOM Tolerable Upper Intake Level (UL) for silymarin — it is a botanical extract, not a vitamin or mineral; no formal UL has been set by NIH ODS or the Institute of Medicine.
- In vitro inhibition of CYP3A4 and CYP2C9 demonstrated; however, human pharmacokinetic studies at typical oral doses (420–700 mg/day silymarin) found no clinically significant effect on CYP1A2, CYP2D6, or CYP3A4/5. A small CYP2C9 effect remains possible; caution is warranted with narrow-therapeutic-index CYP2C9 substrates (warfarin, phenytoin, diazepam, some statins, some antifungals).
- Clinically significant pharmacokinetic interaction with simeprevir and other HCV direct-acting antivirals — concurrent use is contraindicated per prescribing guidance.
- Asteraceae/Compositae cross-reactivity: persons allergic to ragweed, chrysanthemums, daisies, or marigolds may experience allergic reactions to milk thistle and should avoid it.
- Insufficient safety data in pregnancy and lactation — NCCIH advises caution; use should be avoided until adequate evidence is available.
- Mild in vitro phytoestrogenic activity reported; clinical magnitude at typical oral doses is not established. Theoretical concern in estrogen-sensitive conditions (ER+ breast cancer history, estrogen-dependent endometriosis, concurrent hormonal therapy).
- GI adverse effects (bloating, nausea, flatulence, diarrhea, dyspepsia, laxative effect) reported in 2–10% of users at recommended doses — paradoxically, these overlap with symptoms for which the compound is sometimes marketed.
- Quality control concern: commercial milk thistle supplements show highly variable silymarin content (often substantially different from label claims) and documented pesticide, mycotoxin, and microbial contamination; inconsistent clinical outcomes across studies may partly reflect product quality variation.
- At therapeutic doses, milk thistle causes bloating, nausea, flatulence, and GI upset in approximately 2–10% of users; a user taking silymarin for bloating may experience initial worsening of the target symptom — this paradox is most clinically relevant precisely for the GI/bloating indication and should be disclosed
When to take it
Best taken: with food
What we make of it
The bile-flow mechanism we claim is not well established in people.
The detail
Milk thistle is established as protecting liver cells through antioxidant and anti-inflammatory action. Directly stimulating bile flow, which is what our mechanism claims, is not well demonstrated in humans — so the reasoning behind the bloating claim does not hold up.